1|Page
REGIS NU641 CLINICAL ADV PHARMACOLOGY FINAL
EXAM ||VERIFIED EXAM!!|| MOST RECENT EXAM
ACTUAL COMPLETE REAL EXAM QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS)
ALREADY GRADED A+ | GUARANTEED SUCCESS!!
NEWEST EXAM!!!
Absolute contraindications to estrogen therapy include:
1. History of any type of cancer
2. Clotting disorders
3. History of tension headaches
4. Orthostatic hypotension - Answer-2
Postmenopausal women with an intact uterus should not
be prescribed:
1. Estrogen/progesterone combination
2. IM medroxyprogesterone (Depo Provera)
3. Estrogen alone
4. Androgens - Answer-3
Women who have migraines with an aura should not be
prescribed estrogen because of:
,2|Page
1. The interaction between triptans and estrogen, limiting
migraine therapy choices
2. An increased incidence of migraines with the use of
estrogen
3. An increased risk of stroke occurring with estrogen use
4. Patients with migraines may be prescribed estrogen
without any concerns - Answer-3
A 22-year-old woman receives a prescription for oral
contraceptives. Education for this patient includes:
1. Counseling regarding decreasing or not smoking while
taking oral contraceptives
2. Advising a monthly pregnancy test for the first 3 months
she is taking the contraceptive
3. Advising that she may miss two pills in a row and not be
concerned about pregnancy
4. Recommending that her next follow-up visit is in 1 year
for a refill and annual exam - Answer-1
A 19-year-old female is a nasal Staph aureus carrier and
is placed on 5 days of rifampin for treatment. Her only
other medication is combined oral contraceptives. What
education should she receive regarding her medications?
,3|Page
1. Separate the oral ingestion of the rifampin and oral
contraceptive by at least an hour.
2. Both medications are best tolerated if taken on an
empty stomach.
3. She should use a back-up method of birth control such
as condoms for the rest of the current pill pack.
4. If she gets nauseated with the medications she should
call the office for an antiemetic prescription. - Answer-3
A 56-year-old woman is complaining of vaginal dryness
and dyspareunia. To treat her symptoms with the lowest
adverse effects she should be prescribed:
1. Low-dose oral estrogen
2. A low-dose estrogen/progesterone combination
3. A vaginal estradiol ring
4. Vaginal progesterone cream - Answer-3
Shana is receiving her first medroxyprogesterone (Depo
Provera) injection. Shana will need to be monitored for:
1. Depression
2. Hypertension
3. Weight loss
, 4|Page
4. Cataracts - Answer-1
When prescribing medroxyprogesterone (Depo Provera)
injections, essential education would include advising of
the following potential adverse drug effects:
1. Hypertension and dysuria
2. Depression and weight gain
3. Abdominal pain and constipation
4. Orthostatic hypotension and dermatitis - Answer-2
The medroxyprogesterone (Depo Provera) injection has a
Black Box Warning due to:
1. The potential development of significant hypertension
2. Increased risk of strokes
3. Decreased bone density
4. The risk of a life-threatening rash such as Stevens-
Johnson - Answer-3
Shana received her first medroxyprogesterone (Depo
Provera) injection 6 weeks ago and calls the clinic with a
concern that she has been having a light "period" off and
REGIS NU641 CLINICAL ADV PHARMACOLOGY FINAL
EXAM ||VERIFIED EXAM!!|| MOST RECENT EXAM
ACTUAL COMPLETE REAL EXAM QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS)
ALREADY GRADED A+ | GUARANTEED SUCCESS!!
NEWEST EXAM!!!
Absolute contraindications to estrogen therapy include:
1. History of any type of cancer
2. Clotting disorders
3. History of tension headaches
4. Orthostatic hypotension - Answer-2
Postmenopausal women with an intact uterus should not
be prescribed:
1. Estrogen/progesterone combination
2. IM medroxyprogesterone (Depo Provera)
3. Estrogen alone
4. Androgens - Answer-3
Women who have migraines with an aura should not be
prescribed estrogen because of:
,2|Page
1. The interaction between triptans and estrogen, limiting
migraine therapy choices
2. An increased incidence of migraines with the use of
estrogen
3. An increased risk of stroke occurring with estrogen use
4. Patients with migraines may be prescribed estrogen
without any concerns - Answer-3
A 22-year-old woman receives a prescription for oral
contraceptives. Education for this patient includes:
1. Counseling regarding decreasing or not smoking while
taking oral contraceptives
2. Advising a monthly pregnancy test for the first 3 months
she is taking the contraceptive
3. Advising that she may miss two pills in a row and not be
concerned about pregnancy
4. Recommending that her next follow-up visit is in 1 year
for a refill and annual exam - Answer-1
A 19-year-old female is a nasal Staph aureus carrier and
is placed on 5 days of rifampin for treatment. Her only
other medication is combined oral contraceptives. What
education should she receive regarding her medications?
,3|Page
1. Separate the oral ingestion of the rifampin and oral
contraceptive by at least an hour.
2. Both medications are best tolerated if taken on an
empty stomach.
3. She should use a back-up method of birth control such
as condoms for the rest of the current pill pack.
4. If she gets nauseated with the medications she should
call the office for an antiemetic prescription. - Answer-3
A 56-year-old woman is complaining of vaginal dryness
and dyspareunia. To treat her symptoms with the lowest
adverse effects she should be prescribed:
1. Low-dose oral estrogen
2. A low-dose estrogen/progesterone combination
3. A vaginal estradiol ring
4. Vaginal progesterone cream - Answer-3
Shana is receiving her first medroxyprogesterone (Depo
Provera) injection. Shana will need to be monitored for:
1. Depression
2. Hypertension
3. Weight loss
, 4|Page
4. Cataracts - Answer-1
When prescribing medroxyprogesterone (Depo Provera)
injections, essential education would include advising of
the following potential adverse drug effects:
1. Hypertension and dysuria
2. Depression and weight gain
3. Abdominal pain and constipation
4. Orthostatic hypotension and dermatitis - Answer-2
The medroxyprogesterone (Depo Provera) injection has a
Black Box Warning due to:
1. The potential development of significant hypertension
2. Increased risk of strokes
3. Decreased bone density
4. The risk of a life-threatening rash such as Stevens-
Johnson - Answer-3
Shana received her first medroxyprogesterone (Depo
Provera) injection 6 weeks ago and calls the clinic with a
concern that she has been having a light "period" off and
